Department of Internal Medicine

Organization profile

Organisation profile

We are part of university—National Cheng Kung University, therefore, all of our staffs contribute significant amount of time to research and teaching, in addition to clinical service. We accept interns and visiting clerks from the other schools, including foreign students. Our colleagues have established close connections with national and international academic societies. We all expect our department develop an ideal environment for students to learn medicine and is the best place for patients to treat their diseases. ◎ Our Department has 11 divisions, including all the adults’ diseases; the divisions are Cardiology, Chest Medicine, Gastroenterology, Nephrology, Hemato-oncology, Rheumatology and Immunology, Endocrinology and Metabolism, Infection, Geriatrics, Critical care medicine and General medicine. We have 79 staffs (full-time attending physicians), 61 in training residents (R1 to R5), and 47 part-time attending physicians. Besides the residents, we have 19 interns (3 months, 4 shifts per year), 12 junior (6 weeks, 6 shifts per year) and 12 senior clerks (6 weeks, 6 shifts per year) participate our medical teams. They are medical students equal to PGY 1, the third and forth year’s students in the U. S. system.

Fingerprint Dive into the research topics where Department of Internal Medicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Taiwan Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Helicobacter pylori Medicine & Life Sciences
Bacteremia Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Klebsiella pneumoniae Medicine & Life Sciences
Infection Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1995 2018

Research Output 1987 2019

1 Citation (Scopus)

1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase

Lai, M. J., Ojha, R., Lin, M. H., Liu, Y. M., Lee, H. Y., Lin, T. E., Hsu, K. C., Chang, C. Y., Chen, M. C., Nepali, K., Chang, J-Y. & Liou, J. P., 2019 Jan 15, In : European Journal of Medicinal Chemistry. 162, p. 612-630 19 p.

Research output: Contribution to journalArticle

Benzamides
Histone Deacetylases
Tubulin
Heterografts
Cells
Open Access
Klebsiella pneumoniae
Taiwan
Pseudomonas aeruginosa
Intensive Care Units
Imipenem

A subanalysis of Taiwanese patients from ODYSSEY South Korea and Taiwan study evaluating the efficacy and safety of alirocumab

Chao, T-H., Hsiao, P. J., Liu, M. E., Wu, C. J., Chiang, F. T., Chen, Z. C., Chen, C. P., Yeh, H. I., Lee, T. H. & Chiang, C. E., 2019 Jan 1, In : Journal of the Chinese Medical Association. 82, 4, p. 265-271 7 p.

Research output: Contribution to journalArticle

Republic of Korea
Taiwan
LDL Cholesterol
Safety
Placebos